Samuel Darko

Samuel Darko

Auto-generated profile, based on publicly available information

Samuel Darko

Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2021 in Science
Verified
Journal Article
Open access
PDF file
LWLingshu Wang
Lingshu Wang
TZTongqing Zhou
Tongqing Zhou
YZYi Zhang
Yi Zhang
EYEun Sung Yang
Eun Sung Yang
CSChaim A. Schramm
Chaim A. Schramm
JMJohn Misasi
John Misasi
Defenses against SARS-CoV-2 variants: Our key defense against the COVID-19 pandemic is neutralizing antibodies against the SARS-CoV-2 virus elicited by natural infection or vaccination. Recent emerging viral variants have raised concern because of their potential to escape antibody neutralization. Wang et al . identified four antibodies from early-outbreak convalescent donors that are potent against 23 variants, including variants of concern, and characterized their binding to the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Yuan et al . examined the impact of emerging mutations in the receptor-binding domain of the spike protein on binding to the host receptor ACE2 and to a range of antibodies. These studies may be helpful for developing more broadly effective vaccines and therapeutic antibodies. —VV

18 December 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SNSon Nguyen
Son Nguyen
CDClaire Deleage
Claire Deleage
SDSamuel Darko
Samuel Darko
ARAmy Ransier
Amy Ransier
DTDuc P. Truong
Duc P. Truong
MBMichael R. Betts
Michael R. Betts
Elite control of HIV replication is linked to polyfunctional lymphoid CD8 + T cells that lack overt cytolytic activity and home to B cell follicles.

10 December 2020 in Cell
Verified
Journal Article
Closed access
MBMarcus Buggert
Marcus Buggert
LVLaura A. Vella
Laura A. Vella
SNSon Nguyen
Son Nguyen
VWVincent H. Wu
Vincent H. Wu
ZCZeyu Chen
Zeyu Chen
MBMichael R. Betts
Michael R. Betts

5 April 2021 in Immunity
Verified
Journal Article
Closed access
MMMaryam Mukhamedova
Maryam Mukhamedova
DWDaniel Wrapp
Daniel Wrapp
CSChen-Hsiang Shen
Chen-Hsiang Shen
MGMorgan S.A. Gilman
Morgan S.A. Gilman
TRTracy J. Ruckwardt
Tracy J. Ruckwardt
JMJohn Mascola
John Mascola

1 March 2024 in Science
Verified
Journal Article
Open access
MMMarie Materna
Marie Materna
ODOttavia M. Delmonte
Ottavia M. Delmonte
MBMarita Bosticardo
Marita Bosticardo
MMMana Momenilandi
Mana Momenilandi
PCPeyton E. Conrey
Peyton E. Conrey
Vivien BéziatVivien Béziat
Vivien Béziat
We describe humans with rare biallelic loss-of-function PTCRA variants impairing pre–α T cell receptor (pre-TCRα) expression. Low circulating naive αβ T cell counts at birth persisted over time, with normal memory αβ and high γδ T cell counts. Their TCRα repertoire was biased, which suggests that noncanonical thymic differentiation pathways can rescue αβ T cell development. Only a minority of these individuals were sick, with infection, lymphoproliferation, and/or autoimmunity. We also report that 1 in 4000 individuals from the Middle East and South Asia are homozygous for a common hypomorphic PTCRA variant. They had normal circulating naive αβ T cell counts but high γδ T cell counts. Although residual pre-TCRα expression drove the differentiation of more αβ T cells, autoimmune conditions were more frequent in these patients compared with the general population.

26 March 2021 in Science
Verified
Journal Article
Closed access
PDF file
KMKimberly A. Morrissey
Kimberly A. Morrissey
MWMarcin Wegrecki
Marcin Wegrecki
TPT. Praveena
T. Praveena
VHVictoria L. Hansen
Victoria L. Hansen
LBLijing Bu
Lijing Bu
JNJerome Le Nours
Jerome Le Nours
In non-eutherians, a third type of T cell: The two established T cell lineages found in jawed vertebrates use either an αβ or a γδ T cell receptor (TCR) to detect antigens. Recently, another type of TCR chain (TCRµ) was found in marsupials and monotremes. Morrissey et al. analyzed T cells from the gray short-tailed opossum and uncovered a third lineage resident in the spleen that uses a γµ TCR (see the Perspective by Criscitiello). The authors then characterized the crystal structures of two different γµ TCRs, which exhibited an architecture distinct from αβ or γδ TCRs in which a highly diverse, unpaired immunoglobulin-like variable domain was predicted to be the major antigen recognition determinant. Like camelid VHH and shark IgNAR antibodies, γµ TCRs could potentially inform future nanobody development. Science , this issue p. 1383 ; see also p. 1308